Total Payments
$109,236
2024 Payments
$20,237
Companies
26
Transactions
157
Payment Breakdown by Category
Consulting$87,160 (79.8%)
Other$10,375 (9.5%)
Travel$4,611 (4.2%)
Food & Beverage$4,050 (3.7%)
Research$2,925 (2.7%)
Education$113.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $87,160 | 34 | 79.8% |
| Honoraria | $10,375 | 4 | 9.5% |
| Travel and Lodging | $4,611 | 22 | 4.2% |
| Food and Beverage | $4,050 | 94 | 3.7% |
| Unspecified | $2,925 | 1 | 2.7% |
| Education | $113.99 | 2 | 0.1% |
Payments by Type
General
$106,311
156 transactions
Research
$2,925
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $23,714 | 34 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $22,727 | 23 | $0 (2020) |
| Amgen Inc. | $17,391 | 12 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $8,940 | 7 | $0 (2021) |
| GENZYME CORPORATION | $8,310 | 7 | $0 (2023) |
| PFIZER INC. | $6,805 | 17 | $0 (2018) |
| UCB SA | $5,102 | 7 | $0 (2019) |
| MAYNE PHARMA INC. | $2,925 | 1 | $0 (2020) |
| Promius Pharma LLC | $2,662 | 3 | $0 (2017) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $2,641 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,237 | 35 | Amgen Inc. ($11,944) |
| 2023 | $9,420 | 13 | Amgen Inc. ($5,425) |
| 2022 | $2,068 | 5 | GENZYME CORPORATION ($1,980) |
| 2021 | $7,491 | 2 | GENZYME CORPORATION ($4,291) |
| 2020 | $13,782 | 10 | Regeneron Pharmaceuticals, Inc. ($10,380) |
| 2019 | $19,126 | 26 | Regeneron Pharmaceuticals, Inc. ($11,091) |
| 2018 | $28,321 | 44 | Regeneron Healthcare Solutions, Inc. ($18,864) |
| 2017 | $8,790 | 22 | PFIZER INC. ($3,615) |
All Payment Transactions
157 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $3,010.00 | General |
| 11/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,387.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/06/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: DERMATOLOGY | ||||||
| 09/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: DERMATOLOGY | ||||||
| 08/27/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 07/25/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: DERMATOLOGY | ||||||
| 07/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $50.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $86.69 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2024 | LNHC, Inc | — | Honoraria | Cash or cash equivalent | $2,275.00 | General |
| 07/11/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | — | Consulting Fee | Cash or cash equivalent | $922.50 | General |
| 07/11/2024 | LNHC, Inc | — | Food and Beverage | In-kind items and services | $57.81 | General |
| 07/11/2024 | LNHC, Inc | — | Food and Beverage | In-kind items and services | $8.97 | General |
| 07/11/2024 | LNHC, Inc | — | Food and Beverage | In-kind items and services | $7.44 | General |
| 07/03/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: DERMATOLOGY | ||||||
| 06/11/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 06/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: DERMATOLOGY | ||||||
| 05/23/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 05/21/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,975.00 | General |
| 05/08/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: DERMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LAMELLAR ICHTHYOSIS PHASE II | MAYNE PHARMA INC. | $2,925 | 1 |
About Dr. Moise Levy, MD
Dr. Moise Levy, MD is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013097419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Moise Levy, MD has received a total of $109,236 in payments from pharmaceutical and medical device companies, with $20,237 received in 2024. These payments were reported across 157 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($87,160).
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Pediatric Dermatology
- Location Austin, TX
- Active Since 10/17/2006
- Last Updated 01/10/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013097419
Products in Payments
- DUPIXENT (Biological) $34,505
- DUPIXENT DUPILUMAB INJECTION (Biological) $20,338
- EUCRISA (Drug) $6,805
- ABSORICA (Drug) $5,740
- Winlevi (Drug) $3,200
- Cloderm Cream (Drug) $2,662
- HYFTOR (Drug) $414.72
- Hylatopic (Drug) $379.90
- VYJUVEK (Drug) $227.64
- Cimzia (Drug) $172.47
- SILIQ (Drug) $151.95
- TREMFYA (Drug) $130.01
- VTAMA (Drug) $100.69
- COSENTYX (Biological) $95.17
- ELIDEL (Drug) $81.34
- ADBRY (Biological) $50.93
- Sitavig (Drug) $43.43
- ONEXTON (Drug) $33.76
- Enbrel (Biological) $21.84
- Otezla (Drug) $9.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Dermatology $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Dermatology $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Dermatology $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608
Dermatology $231,608